Compare VERA & BBWI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VERA | BBWI |
|---|---|---|
| Founded | 2016 | 1963 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Clothing/Shoe/Accessory Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.4B | 4.0B |
| IPO Year | 2021 | 1994 |
| Metric | VERA | BBWI |
|---|---|---|
| Price | $39.90 | $22.91 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 10 | 16 |
| Target Price | ★ $80.56 | $25.18 |
| AVG Volume (30 Days) | 835.9K | ★ 4.5M |
| Earning Date | 05-27-2026 | 06-02-2026 |
| Dividend Yield | N/A | ★ 3.57% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 1.17 |
| Revenue | N/A | ★ $7,307,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $445.28 | N/A |
| P/E Ratio | ★ N/A | $19.04 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $18.53 | $14.28 |
| 52 Week High | $56.05 | $35.21 |
| Indicator | VERA | BBWI |
|---|---|---|
| Relative Strength Index (RSI) | 38.05 | 51.37 |
| Support Level | $19.84 | $20.52 |
| Resistance Level | $56.05 | $23.73 |
| Average True Range (ATR) | 1.86 | 1.07 |
| MACD | -0.21 | -0.17 |
| Stochastic Oscillator | 16.45 | 46.54 |
Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.
Bath & Body Works is a specialty home fragrance and fragrant body care retailer operating under the Bath & Body Works, C.O. Bigelow, and White Barn brands. The company generates most of its business in North America, with just 5% of sales from international markets in fiscal 2024. For fiscal 2024, 76% of sales stemmed from the brick-and-mortar network (which was composed of more than 1,800 retail stores), similar to 2023 levels, as consumer shopping patterns remained to normal. Future growth is expected from store upgrades, digital and international channels, as well as adjacent category expansions like men's and lip.